Nuvectis Pharma (NVCT) Short Interest
Nasdaq • NVCT • US67080T1088
As of Oct 29, 2026, ORTEX estimated 14.8% of free float sold short, 19.8 days to cover, cost to borrow 0.69%. Sign up for live short interest data.
Nasdaq • NVCT • US67080T1088
As of Oct 29, 2026, ORTEX estimated 14.8% of free float sold short, 19.8 days to cover, cost to borrow 0.69%. Sign up for live short interest data.
This page tracks how heavily Nuvectis Pharma (Nasdaq:NVCT) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Nuvectis Pharma (Nasdaq: NVCT) has a market capitalization of $696.03M. Last close $20.24 (as of 2026-11-16); 52-week range $5.77 to $29.28. ORTEX data as of 2026-10-29: short interest was 14.84% of free float, 19.8 days to cover and the average cost to borrow was 0.69%. Sign up for live short interest data.